If we have selected the wrong experience for you, please change it above.
Slow decisions in cross-border M&A aren’t a cultural clash—they’re a design flaw. In the third part of our life sciences M&A survey series, we explore how mapping decision rights to risk can bridge the gap between consensus and speed, preserving deal momentum and unlocking full transaction value.
In cross-border M&A, slow decision-making is often explained as a cultural issue. In reality, it is more often the result of decision-making architecture that was never explicitly recalibrated in light of the transaction.
Leaders frequently point to post-close frustrations—opaque approvals, repeated escalations, and revisited decisions—as evidence of integration challenges or cultural mismatch. These dynamics are more accurately understood as the downstream effects of implicit assumptions about the ways decisions are made—both during the deal process and in the end-state organization.
Executives often frame decision outcomes—whether delayed or overly rapid—as a people issue: insufficient empowerment, risk aversion, lack of urgency, or excessive individual discretion. That framing is incomplete.
In cross-border M&A—particularly involving Japanese and non-Japanese organizations—decision friction usually arises because:
These gaps often emerge at deal inception, during strategy formulation, target evaluation, and diligence, and then persist into the end-state operating model if left unresolved. Teams improvise decisions during the transaction, normalize them during integration planning, and institutionalize them post-close.
That means decision speed is an outcome of architecture. When the architecture is implicit, even capable and well-intentioned leaders may default to caution, revalidation, and escalation, particularly in complex, cross-border contexts.
Figure 1: Implicit vs. designed decision-making architecture in cross-border M&A
Decision speed and quality are outcomes of architecture. In cross-border M&A, implicit decision systems amplify delay and rework, while explicitly designed ones align accountability and execution across borders.
A recurring tension in Japanese versus non-Japanese cross-border deals is the perceived trade-off between consensus and speed.
According to Deloitte’s “Beyond borders” publication, many Japanese organizations emphasize nemawashi, the practice of building alignment informally before formal decisions are taken, to reduce downstream execution risk and reach decisions that prove durable later on. By contrast, according to Bloomberg, many US and European organizations emphasize speed, escalation, and clear individual ownership to preserve momentum and capture value quickly.
These approaches are often framed as cultural opposites, but they are not. Both are rational responses to risk. The problem arises when neither side explicitly designs the way it will make decisions during deal strategy and execution, nor how those decision rights will carry into the end-state combined organization. In that vacuum, teams default to their native decision-making norms and friction becomes inevitable.
One of the most common decision-making failures in cross-border M&A is the indiscriminate application of a single decision style across very different types of decisions—whether consensus-driven or individually owned—to span both the deal process itself and post-close integration.
Some decisions genuinely warrant broad alignment. Others require clear ownership and speed. This misalignment rarely causes visible failure. Instead, it produces a series of small delays that compound over time. Approvals take longer than expected, local teams hesitate when they should act, or teams revisit decisions instead of resolving them and moving on. Many organizations later describe these transactions as “almost successful”—strategically sound deals whose value realization lagged expectations because execution momentum quietly dissipated.
Decision-making architecture is the invisible layer that explains this pattern. When decision mechanics are not explicitly matched to risk, reversibility, and timing, organizations default to habit rather than intent. Over time, that default erodes leadership focus, team engagement, and value capture.
For M&A leaders, the implication is clear: They must design decision-making explicitly across the full deal life cycle, not assume it.
At deal inception, leaders should:
These actions do not slow deals down. They reduce friction, protect leadership attention, and allow teams to focus on where they can actually create value.
Cross-border M&A failures are often described as integration problems. In reality, many of them are operating model failures that were locked in before the deal even closed. When integration teams encounter slow decisions, unclear authority, or persistent escalation loops, the root cause is usually not execution discipline or cultural resistance. It is more likely the absence of a clearly articulated operating model—one that defines how the combined organization will actually run, make decisions, and allocate control across geographies.
This friction is visible well before integration begins, reinforcing a central finding of this series: Many post-merger integration failures are rooted in pre-close ambiguity, not post-close execution missteps.
Experienced deal leaders tend to converge on three operating model questions they must answer before integration planning begins. These are not PMI tactics; they are structural design choices.
For M&A leaders, the lesson is not to integrate more quickly, but to design earlier and more deliberately.
Operating model clarity is not an integration deliverable. It is a pre-signing leadership responsibility, refined through sign-to-close. It requires explicit trade-offs about control, autonomy, and decision-making that may feel uncomfortable—but which can be far less costly than resolving them post-close.
Cross-border M&A deals rarely lose value because integration teams fail. They lose it because deal teams ask people to integrate into an operating model that was never clearly defined.
In Japan, as detailed by reports from Bloomberg and Reuters, outbound deal activity has accelerated sharply, supported by governance reform, increased private equity participation, and greater willingness to pursue complex carve-outs and take-private transactions. For Japanese organizations, particularly in life sciences, M&A has become a critical mechanism to access global markets, innovation, and talent, as articulated in Deloitte’s “Beyond borders” publication.
Yet despite these trends, along with experience and capital, executives continue to report uneven value realization related to cross-border M&A. They are seeing missed synergies, slower integration, and momentum loss after close. To understand why, we surveyed 126 global life sciences executives who have direct experience in cross-border M&A involving Japanese and non-Japanese organizations. We also interviewed a dozen more in the US, Europe, and Asia Pacific. The results point to a clear conclusion: Organizations broadly agree on what makes cross-border M&A difficult, but they diverge sharply on the reasons deals struggle and where in the process they are actually losing value.
Endnotes:
*Throughout this article, figures reflect multi-select survey responses; percentages indicate frequency of selection rather than relative importance and are best interpreted directionally and comparatively across segments.